TNFSF10 and metabolic dysfunction-associated steatohepatitis: Second, in response to a HFD with cholesterol, mice with TRAIL-deletion develop a marked increase in hepatic steatosis, display altered hepatic cholesterol and glucose homeostasis, and many features of NASH.